Table 3.
Essential oil studies against S. aureus.
Essential oila | Methodb | Species strainc | Solventd | Resulte | Main componentsf | Reference |
---|---|---|---|---|---|---|
Abies balsamea (fir/balsam) | MIC | S. aureus (ATCC 6538) | Acetone | 3.00 mg/mL | β-Pinene (31.00%), bornyl acetate (14.90%), δ-3-carene (14.20%) | [99] |
| ||||||
Abies holophylla (Manchurian fir) | MIC | S. aureus (ATCC 25923) | 5% DMSO | 21.80 mg/mL | Bicyclo[2.2.1]heptan-2-ol (28.05%), δ-3-carene (13.85%), α-pinene (11.68%), camphene (10.41%) | [111] |
S. aureus (ATCC 6538) | >21.80 mg/mL | |||||
Abies koreana (Korean fir) | MIC | S. aureus (ATCC 25923) | 5% DMSO | 21.80 mg/mL | Bornyl ester (41.79%), camphene (15.31%), α-pinene (11.19%) | |
S. aureus (ATCC 6538) | >21.80 mg/mL | |||||
| ||||||
Achillea millefolium (yarrow) | MIC | S. aureus (ATCC 25923) | Tween 80 | 72.00 mg/mL | Eucalyptol (24.60%), camphor (16.70%), α-terpineol (10.20%) | [112] |
| ||||||
Achillea setacea (bristly yarrow) | MIC | S. aureus (ATCC 25923) | Tween 80 | 4.50 mg/mL | Sabinene (10.80%), eucalyptol (18.50%) | [113] |
| ||||||
Angelica archangelica (angelica), root | MIC | S. aureus (ATCC 6538) | Acetone | 1.75 mg/mL | α-Phellandrene (18.50%), α-pinene (13.70%), β-phellandrene (12.60%), δ-3-carene (12.1%) | [99] |
Angelica archangelica (angelica), seed | 2.00 mg/mL | β-Phellandrene (59.20%) | ||||
| ||||||
Anthemis aciphylla var. discoidea (chamomile), flowers | MIC | S. aureus (ATCC 6538) | DMSO | 1.00 mg/mL | α-Pinene (39.00%), terpinen-4-ol (32.10%) | [114] |
Anthemis aciphylla var. discoidea (chamomile), aerial parts | 0.50 mg/mL | α-Pinene (49.40%), terpinen-4-ol (21.80%) | ||||
Anthemis aciphylla var. discoidea (chamomile), leaves | Terpinen-4-ol (24.30%) | |||||
| ||||||
Anthemis nobilis (chamomile) | MIC | S. aureus (ATCC 6538) | Acetone | 16.00 mg/mL | 2-Methylbutyl-2-methyl propanoic acid (31.50%), limonene (18.30%), 3-methylpentyl-2-butenoic acid (16.70%), isobutyl isobutyrate (10.00%) | [99] |
| ||||||
Artemisia dracunculus (tarragon) | MIC | S. aureus (ATCC 6538) | Acetone | 3.00 mg/mL | Estragole (82.60%) | [99] |
| ||||||
Backhousia citriodora (lemon myrtle) | ADM | S. aureus (NCTC 4163) | Tween 20 | 0.05% v/v | Geranial (51.40%), neral (40.90%) | [115] |
MRSA (clinical isolate) | 0.20% v/v | |||||
| ||||||
Boswellia carteri (frankincense) (9 samples) | MIC | S. aureus (ATCC 12600) | Acetone | 5.00–16.00 mg/mL | α-Pinene (4.80–40.40%), myrcene (1.60–52.40%), limonene (1.90–20.40%), α-thujene (0.30–52.40%), p-cymene (2.70–16.90%), β-pinene (0.30–13.10%) | [116] |
Boswellia frereana (frankincense) (3 samples) | 4.00–12.00 mg/mL | α-Pinene (2.00–64.70%), α-thujene (0.00–33.10%), p-cymene (5.40–16.90%) | ||||
Boswellia neglecta (frankincense) | 6.00 mg/mL | NCR | [117] | |||
α-Pinene (43.40%), β-pinene (13.10%) | [116] | |||||
Boswellia papyrifera (frankincense) | 1.50 mg/mL | NCR | [117] | |||
Boswellia rivae (frankincense) | 2.50 mg/mL | |||||
Boswellia sacra (frankincense) (2 samples) | 4.00–8.00 mg/mL | α-Pinene (18.30–28.00%), α-thujene (3.90–11.20%), limonene (11.20–13.10%) | [116] | |||
Boswellia spp. (frankincense) (4 samples) | 6.00–9.30 mg/mL | α-Pinene (18.80–24.20%), limonene (11.70–19.00%) | ||||
Boswellia thurifera (frankincense) | 10.00 mg/mL | α-Pinene (28.0%), limonene (14.6%) | ||||
| ||||||
Cananga odorata (ylang-ylang) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Bicyclosesquiphellandrene (19.50%), β-farnesene (13.90%) | [99] |
Cananga odorata (ylang-ylang), heads | 4.00 mg/mL | Benzyl acetate (31.90%), linalool (27.00%), methyl benzoate (10.40%) | ||||
| ||||||
Canarium luzonicum (elemi) | MIC | S. aureus (ATCC 6538) | Acetone | 3.00 mg/mL | Limonene (41.90%), elemol (21.60%), α-phellandrene (11.40%) | [99] |
| ||||||
Carum carvi (caraway) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Limonene (27.60%), carvone (67.50%) | [99] |
S. aureus | DMSO | ≤1.00 μg/mL | DL-limonene (53.35%), β-selinene (11.08%), β-elemene (10.09%) | [118] | ||
| ||||||
Caryophyllus aromaticus (clove) | ADM90 | S. aureus (ATCC 25923, 16 MRSA and 15 MSSA clinical isolates) | Tween 80 | 2.70 mg/mL | Eugenol (75.85%), eugenol acetate (16.38%) | [119] |
| ||||||
Cinnamomum Cassia (cinnamon) | MIC | S. aureus | DMSO | ≤1.00 μg/mL | trans-Caryophyllene (17.18%), eugenol (14.67%), | [118] |
Linalool L (14.52%), trans-cinnamyl acetate (13.85%), cymol (11.79%), cinnamaldehyde (11.25%) | ||||||
| ||||||
Cinnamomum zeylanicum (cinnamon) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Eugenol (80.00%) | [99] |
MIC | S. aureus (ATCC 25923) | n.m. | 0.02 mg/mL | NCR | [85] | |
ADM | 10% DMSO | 3.20 mg/mL | [80] | |||
ADM90 | S. aureus (ATCC 25923, 16 MRSA and 15 MSSA clinical isolates) | Tween 80 | 0.25 mg/mL | Cinnamaldehyde (86.31%) | [119] | |
| ||||||
Citrus aurantifolia (lime) | ADM | S. aureus (ATCC 25923) | 10% DMSO | 12.80 mg/mL | Cinnamaldehyde (52.42%) | [80] |
| ||||||
Citrus aurantium (bitter orange), flowers | MIC | S. aureus (ATCC 25923) | 50% DMSO | 0.31 mg/mL | Limonene (27.50%), E-nerolidol (17.50%), α-terpineol (14.00%) | [120] |
MIC | S. aureus (ATCC 6536) | 0.63 mg/mL | ||||
| ||||||
Citrus aurantium (petitgrain) | MIC | S. aureus (ATCC 6536) | Acetone | 4.00 mg/mL | Linalyl acetate (54.90%), linalool (21.10%) | [99] |
| ||||||
Citrus bergamia (bergamot) | MAC | S. aureus (ATCC 6538) | n.m. | 1.25 μL/mL | Bergamol (16.10%), linalool (14.02%), D-limonene (13.76%) | [62] |
| ||||||
Citrus grandis (grapefruit) | MIC | S. aureus (ATCC 6538) | Acetone | 3.00 mg/mL | Limonene (74.80%) | [99] |
| ||||||
Citrus medica limonum (lemon) | ADM | S. aureus (ATCC 25923) | 10% DMSO | >12.80 mg/mL | NCR | [80] |
MIC | S. aureus (ATCC 6538) | Acetone | 3.00 mg/mL | [99] | ||
| ||||||
Citrus sinensis (orange) | ADM | S. aureus (ATCC 25923) | 10% DMSO | >12.80 mg/mL | NCR | [80] |
MAC | S. aureus (ATCC 9144) | 0.1% ethanol | 0.94 mg/L | [121] | ||
MIC | S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | Limonene (93.20%) | [99] | |
| ||||||
Commiphora guidotti (myrrh) | MIC | S. aureus (ATCC 12600) | Acetone | 1.50 mg/mL | (E)-β-Ocimene (52.60%), α-santalene (11.10%), (E)-bisabolene (16.00%) | [117] |
| ||||||
Commiphora myrrha (myrrh) | MIC | S. aureus (ATCC 12600) | Acetone | 1.30 mg/mL | Furanogermacrene (15.90%), furanoeudesma-1,3-diene (44.30%) | [117] |
S. aureus (ATCC 6538) | 2.00 mg/mL | Furanoeudesma-1,3-diene (57.70%), lindestrene (16.30%) | [117] | |||
| ||||||
Coriandrum sativum (coriander), seed | MIC | S. aureus (7 clinical isolates) | 0.5% DMSO with Tween 80 | 0.16 mg/mL | NCR | [122] |
| ||||||
Cupressus arizonica (smooth cypress), branches | MIC | S. aureus (ATCC 25923) | 10% DMSO | 1.50 μg/mL | α-Pinene (58.60%), δ-3-carene (15.60%) | [123] |
Cupressus arizonica (smooth cypress),female cones | 2.95 μg/mL | α-Pinene (60.50%), δ-3-carene (15.30%) | ||||
Cupressus arizonica (smooth cypress), leaves | 0.98 μg/mL | α-Pinene (20.00%), umbellulone (18.40%) | ||||
| ||||||
Cupressus sempervirens (cypress) | MIC | S. aureus (ATCC 6538) | Acetone | 12.00 mg/mL | α-Pinene (41.20%), δ-3-carene (23.70%) | [99] |
| ||||||
Cymbopogon giganteus (lemongrass) | MIC | S. aureus (ATCC 9144) | 0.5% ethanol | 2.10 mg/mL | Limonene (42.00%), trans-p-mentha-1(7),8-dien-2-ol (14.20%), cis-p-mentha-1(7),8-dien-2-ol (12.00%) | [124] |
| ||||||
Cymbopogon citratus (lemongrass) | MIC | S. aureus (ATCC 9144) | 0.5% ethanol | 2.50 mg/mL | Geranial (48.10%), neral (34.60%), myrcene (11.00%) | [124] |
S. aureus | DMSO | ≤1.00 μg/mL | Geranial (47.34%), β-myrcene (16.53%), Z-citral (8.36%) | [118] | ||
MAC | S. aureus (MTCC 96) | Sodium taurocholate | 0.80–0.27 μL/mL | Citral (72.80%) | [125, 126] | |
MIC | S. aureus (ATCC 6538) | Acetone | 1.67 mg/mL | Geranial (44.80%) | [99] | |
| ||||||
Cymbopogon martinii (palmarosa) | MAC | S. aureus (MTCC 96) | Sodium taurocholate | 0.80 μL/mL | Geraniol (61.6%) | [125, 126] |
| ||||||
Cymbopogon nardus (citronella) | MIC | S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | Citronellal (38.30%), geraniol (20.70%), citronellol (18.80%) | [99] |
| ||||||
Daucus carota (carrot seed) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Carotol (44.40%) | [99] |
| ||||||
Eucalyptus camaldulensis (eucalyptus) | MAC | S. aureus (ATCC 25923) | Acetone | 3.90 μg/mL | 1,8-Cineol (54.37%), α-pinene (13.24%) | [127] |
S. aureus (clinical isolate) | ||||||
| ||||||
Eucalyptus globulus (eucalyptus) | MIC | S. aureus (ATCC 25923) | Tween 80 | 10.00 mg/mL | 1,8-Cineol (81.93%) | [128] |
MRSA (ATCC 10442) | ||||||
MRSA (MRSA USA 300) | ||||||
MIC | S. aureus (ATCC 43387) | DMSO | 0.20% v/v | NCR | [129] | |
MAC | S. aureus (MTCC 96) | Sodium taurocholate | 0.41 μL/mL | Cineole (23.20%) | [125, 126] | |
ADM | MRSA (ATCC 33592) | Tween 20 | 85.60 μg/mL | Eucalyptol (47.20%), (+)-spathulenol (18.10%) | [81] | |
S. aureus (ATCC 25922) | 51.36 μg/mL | |||||
MRSA (14 clinical isolates) | 8.56–85.60 μg/mL | |||||
MIC | S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | 1,8-Cineole (58.00%), α-terpineol (13.20%) | [99] | |
MIC | S. aureus (ATCC 25923) | Acetone | 2.00 mg/mL | NCR | [130] | |
MRSA (ATCC 33592) | 0.75 mg/mL | |||||
| ||||||
Eucalyptus radiata (eucalyptus) | MIC | S. aureus (ATCC 25923) | Acetone | 2.00 mg/mL | 1,8-Cineole (65.7% ± 9.5), α-terpineol (12.8% ± 4.4) | [130] |
MRSA (ATCC 33592) | 1.00–2.00 mg/mL | |||||
| ||||||
Eucalyptus camaldulensis (eucalyptus) | MIC | S. aureus (ATCC 25923) | Acetone | 0.50 mg/mL | NCR | [130] |
MRSA (ATCC 33592) | ||||||
| ||||||
Eucalyptus citriodora (eucalyptus) | MIC | S. aureus (ATCC 25923) | Acetone | 1.00 mg/mL | NCR | [130] |
MRSA (ATCC 33592) | ||||||
| ||||||
Eucalyptus smithii (eucalyptus) | MIC | S. aureus (ATCC 25923) | Acetone | 2.00 mg/mL | NCR | [130] |
MRSA (ATCC 33592) | ||||||
| ||||||
Eucalyptus dives (eucalyptus) | MIC | S. aureus (ATCC 25923) | Acetone | 2.00 mg/mL | NCR | [130] |
MRSA (ATCC 33592) | 1.00 mg/mL | |||||
| ||||||
Eucalyptus intertexta (eucalyptus) | MIC | S. aureus (ATCC 29737) | 10% DSMO | 7.80 μg/mL | NCR | [131] |
| ||||||
Eucalyptus largiflorens (eucalyptus) | MAC | S. aureus (ATCC 25923) | n.m. | 7.80 μg/mL | 1,8-Cineol (70.32%), α-pinene (15.46%) | [127] |
S. aureus (clinical isolate) | ||||||
MIC | S. aureus (ATCC 29737) | 10% DSMO | 250.00 μg/mL | NCR | [131] | |
| ||||||
Eucalyptus melliodora (eucalyptus) | MAC | S. aureus (ATCC 25923) | n.m. | 3.90 μg/mL | 1,8-Cineol (67.65%), α-pinene (18.58%) | [127] |
S. aureus (clinical isolate) | ||||||
| ||||||
Eucalyptus polycarpa (eucalyptus) | MAC | S. aureus (ATCC 25923) | n.m. | 1.95 μg/mL | 1,8-Cineol (50.12%) | [127] |
S. aureus (clinical isolate) | 3.90 μg/mL | |||||
| ||||||
Foeniculum dulce (fennel) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | E-Anethole (79.10%) | [99] |
| ||||||
Foeniculum vulgare (fennel) | MAC | S. aureus (ATCC 25923) | DMSO | >10.00 mg/mL | trans-Anethole (68.53%), estragole (10.42%) | [132] |
Foeniculum vulgare (fennel) (6 samples) | MIC | S. aureus | ≤1.00 μg/mL | trans-Anethole (33.3%), DL-limonene (19.66%), carvone (12.03%) | [118] | |
S. aureus (ATCC 28213) | 125.00–500.00 μg/mL | Fenchone (16.90–34.70%), estragole (2.50–66.00%), trans-anethole (7.90–77.70%) | [133] | |||
| ||||||
Foeniculum vulgare Mill. ssp. vulgare (fennel), Aurelio | MAC | S. aureus (ATCC 25923) | Tween 20 | 50.00–100.00 μg/mL | Limonene (16.50–21.50%), (E)-anethole (59.80–66.00%) | [134] |
Foeniculum vulgare Mill. ssp. vulgare (fennel), Spartaco | Limonene (0.20–17.70%), (E)-anethole (66.30–90.40%) | |||||
| ||||||
Geranium dissectum (geranium) | MIC | S. aureus | DMSO | ≤1.00 μg/mL | β-Citronellol (25.45%), geraniol (13.83%) | [118] |
| ||||||
Hyssopus officinalis (hyssop) | MIC | S. aureus (ATCC 6538) | Acetone | 3.00 mg/mL | Isopinocamphone (48.70%), pinocamphone (15.50%) | [99] |
| ||||||
Juniperi aetheroleum (juniper) | MAC80 | S. aureus (ATCC 6538) | n.m. | 40.00% v/v | α-Pinene (29.17%), β-pinene (17.84%), sabinene (13.55%) | [135] |
MAC80 | S. aureus (MFBF) | 15.00% v/v | ||||
| ||||||
Juniperus communis (juniper), berry | MIC | S. aureus (ATCC 25923) | n.m. | 10.00 mg/mL | NCR | [85] |
MIC | MRSA (15 clinical isolates) | Ethanol | >2.00% v/v | [136] | ||
| ||||||
Juniperus excelsa (juniper), berries, Dojran | ADM | S. aureus (ATCC 29213) | 50% DSMO | >50.00% | α-Pinene (70.81%) | [87] |
Juniperus excelsa (juniper), leaves, Dojran | 125.00% | α-Pinene (33.83%) | ||||
Juniperus excelsa (juniper), leaves, Ohrid | 125.00% | Sabinene (29.49%) | ||||
| ||||||
Juniperus officinalis (juniper), berry | MIC | S. aureus (ATCC 29213) | Tween 80 | 10.00 mg/mL | α-Pinene (39.76%) | [128] |
Juniperus officinalis (juniper), berry | MRSA (clinical isolates) | 20.00 mg/mL | ||||
| ||||||
Juniperus virginiana (juniper) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Thujopsene (29.80%), cedrol (14.90%), α-cedrene (12.40%) | [99] |
Juniperus virginiana (juniper), berries | 3.00 mg/mL | α-Pinene (20.50%), myrcene (13.70%), bicyclosesquiphellandrene (10.70%) | ||||
| ||||||
Kunzea ericoides (Kānuka) | MAC | S. aureus (ATCC 6538) | Tween 80 | 0.25% v/v | α-Pinene (61.60%) | [137] |
MRSA (clinical isolate) | 0.20% v/v | |||||
MIC | S. aureus (ATCC 12600) | Acetone | 8.00 mg/mL | α-Pinene (26.2–46.7%), p-cymene (5.8–19.1%) | [138] | |
| ||||||
Laurus nobilis (bay) | MIC | S. aureus (ATCC 6538) | Acetone | 0.83 mg/mL | Eugenol (57.20%), myrcene (14.30%), carvacrol (12.70%) | [99] |
| ||||||
Lavandula angustifolia (lavender) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Linalyl acetate (36.70%), linalool (31.40%), terpinen-4-ol (14.90%) | [99] |
S. aureus (NCTC 6571) | 10% DSMO | 310.00 μg/mL | Linalool (25.10%), linalyl acetate (22.50%) | [139] | ||
S. aureus (NCTC 1803) | 320.40 μg/mL | |||||
MRSA (15 clinical isolates) | Ethanol | 0.50% v/v | NCR | [136] | ||
S. aureus (ATCC 12600) | Acetone | 8.60 mg/mL | Linalool (30.80%), linalyl acetate (31.30%) | [140] | ||
S. aureus (clinical strain and ATCC 6538) | Acetone | 2.00 mg/mL | Linalyl acetate (36.7%), linalool (31.4%), terpinen-4-ol (14.9%) | [99] | ||
MRSA (clinical strain and 43300) | ||||||
Methicillin-gentamicin-resistant S. aureus (MGRSA) (ATCC 33592) | ||||||
| ||||||
Lavandula dentata (French lavender) | MIC | S. aureus (BNI 18) | 5% DMSO | 1.53 mg/mL | Camphor (12.40%) | [141] |
Lavandula officinalis (lavender) | MIC | S. aureus | DMSO | ≤1.00 μg/mL | δ-3-Carene (17.14%), α-fenchene (16.79%), diethyl phthalate (13.84%) | [118] |
Lavandula stoechas (French lavender) | MIC | S. aureus (STCC 976) | Tween 80 | 2.00 μL/mL | 10s,11s-Himachala-3(12),4-diene (23.62%), cubenol (16.19%) | [142] |
| ||||||
Lavandula stoechas (French lavender), flower | MIC | MRSA (clinical isolate) | 20% DMSO | 31.25 μg/mL | α-Fenchone (39.20%) | [47] |
Lavandula stoechas (French lavender), leaf | 125.00 μg/mL | α-Fenchone (41.90%), 1,8-cineole (15.60%), camphor (12.10%) | ||||
| ||||||
Leptospermum scoparium (manuka) | MAC | S. aureus (ATCC 6538) | Tween 80 | 0.10% v/v | (−)-(E)-Calamenene (14.50%), leptospermone (17.60%) | [137] |
MRSA (clinical isolate) | 0.05% v/v | |||||
MIC | S. aureus (ATCC 12600) | Acetone | 4.00 mg/mL | Eudesma-4(14),11-diene (6.2–14.5%), α-selinene (5.90–13.5%), (E)-methyl cinnamate (9.2–19.5%) | [138] | |
| ||||||
Litsea cubeba (May Chang) | MIC | S. aureus (ATCC 6538) | Acetone | 1.50 mg/mL | Geranial (45.60%), nerol (31.20%) | [99] |
| ||||||
Matricaria chamomilla (German chamomile) | MIC | S. aureus (ATCC 6538) | Acetone | 1.50 mg/mL | Bisabolene oxide A (46.90%), β-farnesene (19.20%) | [99] |
| ||||||
Matricaria recutita (German chamomile) | ADM90 | S. aureus (ATCC 25923, 16 MRSA and 15 MSSA clinical isolates) | Tween 80 | 26.50 mg/mL | Chamazulene (31.48%), α-bisabolol (15.71%), bisabolol oxide (15.71%) | [119] |
| ||||||
Matricaria songarica (chamomile) | MIC | S. aureus (CCTCC AB91093) | Tween 80 | 50.00 μg/mL | E-β-Farnesene (10.58%), bisabolol oxide A (10.46%) | [143] |
| ||||||
Melaleuca alternifolia (tea tree) | ADM | S. aureus (NCIM 2079) | Tween 80 | 1.00% | NCR | [79] |
S. aureus (clinical isolate) | ||||||
MAC | S. aureus (ATCC 6538) | Tween 80 | 0.25% v/v | α-Terpinene (11.40%), γ-terpinene (22.50%), terpinen-4-ol (35.20%) | [137] | |
MRSA (clinical isolate) | 0.35% v/v | |||||
MIC | S. aureus (ATCC 29213) | None used | 0.50% (v/v) | Terpinen-4-ol (40.00%), δ-terpinen (13.00%), p-cymene (13.00%) | [97] | |
MRSA (98 clinical isolates) | n.m. | 512.00–2048.00 mg/L | NCR | [144] | ||
S. aureus (NCIB 6571) | 1.00% v/v | [145] | ||||
Coagulase-negative staphylococci (9 clinical isolates) | Polyoxyl 35 castor oil | 0.63–2.50% v/v | Terpinen-4-ol (>35.00%) | [146] | ||
MRSA (10 clinical isolates) | 0.30–0.63% v/v | |||||
0.30% v/v | ||||||
MRSA (15 clinical isolates) | Ethanol | 0.25% v/v | NCR | [136] | ||
S. aureus (ATCC 12600) | Acetone | 8.60 mg/mL | Terpinen-4-ol (38.60%), γ-terpinene (21.60%) | [140] | ||
MIC90 | S. aureus (NCTC 6571) | Tween 80 | 0.25% v/v | Terpinen-4-ol (35.70%) | [147] | |
S. aureus (105 clinical isolates) | 0.12–0.50% v/v | |||||
MIC | MRSA (60 clinical isolates, 29 mupirocin-resistant) | 0.25% | [148] | |||
MIC | S. aureus (NCTC 8325) | n.m. | 0.50% (v/v) | Terpinen-4-ol (39.80%), γ-terpinene (17.80%) | [149] | |
0.25% (v/v) | [150] | |||||
MIC90 | MRSA (100 clinical isolates) | Tween 80 | 0.16–0.32% | NCR | [151] | |
MIC | S. aureus (69 clinical isolates) | Tween 80 | 0.12–0.50% v/v | Terpinen-4-ol (35.70%) | [152] | |
ADM | S. aureus (NCTC 4163) | Tween 20 | 0.20% v/v | Terpinen-4-ol (42.80%), γ-terpinene (18.20%) | [115] | |
MRSA (clinical isolate) | 0.30% v/v | |||||
MIC | S. aureus (ATCC 6538) | Acetone | 8.00 mg/mL | Terpinen-4-ol (49.30%), γ-terpinene (16.90%) | [99] | |
MAC | S. aureus (2 clinical isolates) | n.m. | 0.10–0.20% | Eucalyptol (70.08%) | [153] | |
S. aureus (ATCC 25923) | 0.20% | |||||
S. aureus (NCTC 9518) | 0.63–1.25% v/v | α-Pinene (11.95%), α-terpinene (14.63%), terpinen-4-ol (29.50%), p-cymene (17.74%) | [154] | |||
α-Pinene (24.87%), α-terpinene (12.47%), terpinen-4-ol (28.59%) | ||||||
| ||||||
Melaleuca cajuputi (cajuput) | MIC | S. aureus (ATCC 25923) | Tween 80 | 2.50 mg/mL | 1,8-Cineol (67.60%) | [128] |
MRSA (ATCC 10442) | 5.00 mg/mL | |||||
MRSA (clinical isolate) | 2.50 mg/mL | |||||
MAC | S. aureus (ATCC 6538) | 0.20% v/v | 1,8-Cineole (55.50%) | [137] | ||
MRSA (clinical isolate) | 0.30% v/v | |||||
| ||||||
Melaleuca quinquenervia (niaouli) | MAC | S. aureus (ATCC 6538) | Tween 80 | 0.20% v/v | 1,8-Cineole (61.20%) | [137] |
MRSA (clinical isolate) | 0.30% v/v | |||||
| ||||||
Melaleuca viridiflora (niaouli) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | 1,8-Cineole (45.90%), α-terpinene (21.00%) | [99] |
| ||||||
Melissa officinalis (lemon balm) | MIC | S. aureus (NCTC 6571) | 10% DSMO | 300.60 μg/mL | 1,8-Cineol (27.40%), α-thujone (16.30%), β-thujone (11.20%), borneol (10.40%) | [139] |
MIC | S. aureus (NCTC 1803) | 330.30 μg/mL | ||||
| ||||||
Mentha piperita (peppermint) | MIC | S. aureus (ATCC 12600) | Acetone | 11.90 mg/mL | Menthone (18.20%), menthol (42.90%) | [140] |
S. aureus (ATCC 25923) | Tween 80 | 0.60 mg/mL | 1,8-Cineol (12.06%), menthone (22.24%), menthol (47.29%) | [128] | ||
MRSA (ATCC 10442) | ||||||
MRSA (clinical isolate) | ||||||
S. aureus (ATCC 6538) | DMSO | 0.63–2.50 mg/mL | Menthol (27.50–42.30%), menthone (18.40–27.90%) | [155] | ||
S. aureus | ≤1.00 μg/mL | Menthone (40.82%), carvone (24.16%) | [118] | |||
MRSA (15 clinical isolates) | Ethanol | 0.50% v/v | NCR | [136] | ||
S. aureus (ATCC 43387) | DMSO | 0.20% v/v | [129] | |||
MAC | S. aureus (MTCC 96) | Sodium taurocholate | 1.66 μL/mL | Menthol (36.40%) | [125, 126] | |
MIC | S. aureus (ATCC 9144) | 0.5% ethanol | 8.30 mg/mL | Menthol (39.30%), menthone (25.20%) | [156] | |
MIC | S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | Menthol (47.50%), menthone (18.60%) | [99] | |
| ||||||
Myrtus communis (myrtle) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Myrtenyl acetate (28.20%), 1,8-cineole (25.60%), α-pinene (12.50%) | [99] |
ADM | S. aureus (ATCC 6538) | Tween 20 | 2.80 mg/mL | NCR | [157] | |
S. aureus (ATCC 29213) | ||||||
| ||||||
Ocimum basilicum (basil) | MIC | S. aureus (ATCC 9144) | 0.5% ethanol | 2.50 mg/mL | Linalool (57.00%), eugenol (19.20%) | [156] |
MAC | S. aureus (ATCC 6538) | n.m. | 1.25 μL/mL | Eugenol (62.60%), caryophyllene (21.51%) | [62] | |
Tween 80 | 0.07 × 10−2% v/v | Linalool (54.95%), methyl chavicol (11.98%) | [158] | |||
S. aureus (3 clinical strains) | Tween 80 | ((0.15–0.30) × 10)−2 % v/v | Linalool (54.95%), methyl chavicol (11.98%) | [158] | ||
MIC | S. aureus (ATCC 6538) | Acetone | 1.50 mg/mL | Linalool (54.10%) | [99] | |
MIC90 | S. aureus (ATCC 6538) | n.m. | 45.00 μg/mL | Methyl chavicol (46.90%), geranial (19.10%), neral (15.15%) | [159] | |
MIC | S. aureus (ATCC 6538) | Tween 80 | 0.68–11.74 μg/mL | Linalool (30.30–58.60%) | [160] | |
| ||||||
Origanum acutidens (Turkey oregano) | MIC | S. aureus (clinical isolate) | 10% DMSO | 125.00 μg/mL | Carvacrol (72.00%) | [161] |
S. aureus (ATCC2913) | ||||||
| ||||||
Origanum majorana (marjoram) | MIC | S. aureus (ATCC 43387) | DMSO | 0.05% v/v | NCR | [129] |
S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | 1,8-Cineole (46.00%), linalool (26.10%) | [99] | ||
| ||||||
Origanum microphyllum (oregano) | MIC | S. aureus (ATCC 25923) | Tween 80 | 6.21 mg/mL | Terpin-4-ol (24.86%), γ-terpinene (13.83%), linalool (10.81%) | [162] |
| ||||||
Origanum scabrum (oregano) | MIC | S. aureus (ATCC 25923) | Tween 80 | 0.35 mg/mL | carvacrol (74.86%) | [162] |
| ||||||
Origanum vulgare (oregano) | ADM | S. aureus (ATCC 6538) | 1% DMSO | 0.13% v/v | p-Cymene (14.60%), γ-terpinene (11.70%), thymol (24.70%), carvacrol (14.00%) | [163] |
S. aureus (ATCC 25923) | ||||||
S. aureus (ATCC 43300) | ||||||
MRSA (22 isolates) | 0.06–0.13% v/v | |||||
MIC | S. aureus (ATCC 6538) | n.m. | 575.00 mg/L | NCR | [164] | |
MAC | 0.63.00 μL/mL | Carvacrol (30.17%), p-cymene (15.20%), γ-terpinen (12.44%) | [62] | |||
MIC | S. aureus (ATCC 43387) | DMSO | 0.10% v/v | NCR | [129] | |
ADM | S. aureus (ATCC 6538) | Tween 20 | 0.70 mg/mL | [157] | ||
S. aureus (ATCC 29213) | ||||||
| ||||||
Origanum vulgare subsp. hirtum (Greek oregano) | MIC | S. aureus (ATCC 25923) | 10% DMSO + Tween 80 | 170.70 μg/mL | Linalool (96.31%) | [165] |
Origanum vulgare subsp. vulgare (oregano) | 106.70 μg/mL | Thymol (58.31%), carvacrol (16.11%), p-cymene (13.45%) | ||||
| ||||||
Pelargonium graveolens (geranium) | ADM | S. aureus (ATCC 25923) | 10% DMSO | >12.80 mg/mL | NCR | [80] |
S. aureus (ATCC 6538) | Tween 20 | 0.72 mg/mL | [157] | |||
S. aureus (ATCC 29213) | ||||||
MIC | S. aureus (strains isolated from skin lesions) | Ethanol | 0.25–1.50 mL/mL | Citronellol (26.70%), geraniol (13.40%) | [166] | |
S. aureus (strains isolated postoperatively) | 0.50–2.25 mL/mL | |||||
MRSA and MSSA (clinical strains) | 1.00 mL/mL | |||||
S. aureus (ATCC 6538) | Acetone | 1.50 mg/mL | Citronellol (34.20%), geraniol (15.70%) | [99] | ||
| ||||||
Perovskia abrotanoides (Russian sage) | MIC | S. aureus (ATCC 25923) | 10% DMSO | 8.00 μL/mL | Camphor (23.00%), 1,8-cineole (22.00%), α-pinene (12.00%) | [167] |
| ||||||
Pimpinella anisum (anise) | MIC | S. aureus | DMSO | 125.00 μg/mL | NCR | [168] |
≤1.00 μg/mL | Anethole (64.82%) | [118] | ||||
| ||||||
Pinus sylvestris (pine) | MIC | S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | Bornyl acetate (42.30%), camphene (11.80%), α-pinene (11.00%) | [99] |
| ||||||
Piper nigrum (black pepper) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | β-Caryophyllene (33.80%), limonene (16.40%) | [99] |
| ||||||
Pogostemon cablin (patchouli) | MIC | S. aureus (NCTC 6571) | 10% DSMO | 395.20 μg/mL | α-Guaiene (13.80%), α-bulnesene (17.10%), patchouli alcohol (22.70%) | [139] |
S. aureus (NCTC 1803) | 520.00 μg/mL | |||||
| ||||||
Pogostemon patchouli (patchouli) | MIC | S. aureus (ATCC 6538) | Acetone | 1.50 mg/mL | Patchouli alcohol (37.30%), α-bulnesene (14.60%), α-guaiene (12.50%) | [99] |
| ||||||
Rosmarinus officinalis (rosemary) | MIC | S. aureus (ATCC 6538) | Tween 80 | 0.13% v/v | 1,8-Cineole (27.23%), α-pinene (19.43%), camphor (14.26%), camphene (11.52%) | [169] |
S. aureus (NCTC 6571) | 10% DSMO | 305.30 μg/mL | 1,8-Cineol (29.2%), (+)-camphor (17.2%) | [139] | ||
S. aureus (NCTC 1803) | 310.40 μg/mL | |||||
MRSA (clinical isolate) | Tween 80 | 0.03% v/v | 1,8-Cineole (26.54%), α-pinene (20.14%), camphene (11.38%), camphor (12.88%) | [170] | ||
S. aureus (MTCC 96) | n.m. | >11.00 mg/mL | NCR | [171] | ||
S. aureus (ATCC 6538) | Hexane | 1.88–7.50 mg/mL | 1,8-Cineole (10.56–11.91%), camphor (16.57–16.89%), verbenone (17.43–23.79%) | [172] | ||
ADM | S. aureus (ATCC 25923) | 10% DMSO | >12.80 mg/mL | NCR | [80] | |
S. aureus (ATCC 6538) | Tween 20 | 5.60 mg/mL | [157] | |||
S. aureus (ATCC 29213) | ||||||
MIC | S. aureus (ATCC 12600) | Acetone | 6.20 mg/mL | 1,8-Cineole (41.40%), α-pinene (13.30%), camphor (12.40%) | [140] | |
S. aureus (ATCC 43387) | DMSO | 0.20% v/v | NCR | [129] | ||
S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | 1,8-Cineole (48.00%) | [99] | ||
ADM90 | S. aureus (ATCC 25923, 16 MRSA and 15 MSSA clinical isolates) | Tween 80 | 8.60 mg/mL | Camphor (27.51%), limonene (21.01%), myrcene (11.19%), α-pinene (10.37%) | [119] | |
| ||||||
Salvia bracteata (sage) | MIC | S. aureus (ATCC 25923) | 50.00 μg/mL | Caryophyllene oxide (16.60%) | [173] | |
Salvia eremophila (sage) | MIC | S. aureus (ATCC 29737) | 10% DMSO | 8.00 μg/mL | Borneol (21.83%), α-pinene (18.80%), bornyl acetate (18.68%) | [174] |
Salvia nilotica (sage) | ADM | S. aureus (ATCC 25923) | n.m. | 5.40 mg/mL | trans-Caryophyllene (10.90%) | [175] |
| ||||||
Salvia officinalis (sage) | MIC | S. aureus (NCTC 6571) | 10% DSMO | 302.40 μg/mL | 1,8-Cineol (27.40%), α-thujone (16.30%), β-thujone (11.20%), borneol (10.40%) | [139] |
S. aureus (NCTC 1803) | 324.30 μg/mL | |||||
S. aureus (ATCC 43387) | DMSO | 0.20% v/v | NCR | [129] | ||
ADM | S. aureus (ATCC 6538) | Tween 20 | 11.20 mg/mL | NCR | [157] | |
S. aureus (ATCC 29213) | 5.60 mg/mL | |||||
S. aureus (ATCC 25923) | n.m. | 7.50 mg/mL | [176] | |||
| ||||||
Salvia ringens (sage) | MIC | S. aureus (ATCC 25923) | n.m. | NI | α-Pinene (12.85%), 1,8-cineole (46.42%) | [177] |
Salvia rosifolia (sage) (3 samples) | MRSA | 20% DMSO | 125.00–1000.00 μg/mL | α-Pinene (15.70–34.80%), 1,8-cineole (16.60–25.10%), β-pinene (6.70–13.50%) | [178] | |
Salvia rubifolia (sage) | S. aureus (ATCC 25923) | Tween 20 | 50.00 μg/mL | γ-Muurolene (11.80%) | [173] | |
| ||||||
Salvia sclarea (clary sage) | MIC | S. aureus (11 MRSA and 16 MSSA) | Ethanol | 3.75–5.25 | Linalyl acetate (57.90%), linalool (12.40%) | [179] |
S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | Linalyl acetate (72.90%), linalool (11.90%) | [99] | ||
| ||||||
Santalum album (sandalwood) | MIC | S. aureus (ATCC 6538) | Acetone | 0.25 mg/mL | α-Santalol (32.10%) | [99] |
| ||||||
Styrax benzoin (benzoin) | MIC | S. aureus (ATCC 6538) | Acetone | 2.00 mg/mL | cinnamyl alcohol (44.80%), benzene propanol (21.70%) | [99] |
| ||||||
Syzygium aromaticum (clove) | MIC | S. aureus (ATCC 6538) | Tween 80 | 0.13% v/v | Eugenol (68.52%), β-caryophyllene (19.00%), 2-methoxy-4-[2-propenyl]phenol acetate (10.15%) | [169] |
S. aureus | DMSO | ≤1.00 μg/mL | Eugenol (84.07%), isoeugenol (10.39%) | [118] | ||
ADM | S. aureus (ATCC 25923) | 10% DMSO | >6.40 mg/mL | NCR | [80] | |
MIC | S. aureus (ATCC 6538) | Acetone | 1.50 mg/mL | Eugenol (82.20%), eugenol acetate (13.20%) | [99] | |
| ||||||
Tagetes minuta (Mexican marigold) | MIC90 | S. aureus (ATCC 6538) | n.m. | 67.00 μg/mL | Dihydrotagetone (33.90%), E-ocimene (19.90%), tagetone (16.10%) | [159] |
Tagetes patula (French marigold) | MIC | S. aureus (ATCC 6538) | Acetone | 4.00 mg/mL | (E)-β-Ocimene (41.30%), E-tagetone (11.20%), verbenone (10.90%) | [99] |
| ||||||
Thymbra spicata (thyme) | MIC | S. aureus (ATCC 29213) | Tween 80 | 2.25 mg/mL | Carvacrol (60.39%), γ-terpinene (12.95%) | [180] |
Thymus capitatus (thyme) | S. aureus (ATCC 25923) | 900.00 μg/mL | p-Cymene (26.40%), thymol (29.30%), carvacrol (10.80%) | [181] | ||
Thymus capitatus (thyme), commercial | α-Pinene (25.20%), linalool (10.30%), thymol (46.10%) | |||||
Thymus herba-barona (thyme), Gennargentu | 225.00 μg/mL | Thymol (46.90%), carvacrol (20.60%) | ||||
Thymus herba-barona (thyme), Limbara | 900.00 μg/mL | p-Cymene (27.60%), thymol (50.30%) | ||||
| ||||||
Thymus hyemalis (thyme) (thymol, thymol/linalool, carvacrol chemotypes) | MAC | S. aureus (CECT 239) | 95% ethanol | <0.20–0.50 μL/mL | p-Cymene (16.00–19.80%), linalool (2.10–16.60%), thymol (2.90–43.00%), carvacrol (0.30–40.10%) | [61] |
| ||||||
Thymus numidicus | ADM | S. aureus (ATCC 25923) | n.m. | 0.23 mg/mL | NCR | [176] |
Thymus serpyllum (thyme) | S. aureus (ATCC 6538) | Tween 20 | 0.28 mg/mL | [157] | ||
S. aureus (ATCC 29213) | 0.70 mg/mL | |||||
| ||||||
Thymus vulgaris (thyme) | MIC | S. aureus | DMSO | 31.20 μg/mL | NCR | [168] |
S. aureus (NCTC 6571) | 10% DSMO | 160.50 μg/mL | p-Cymene (17.90%), thymol (52.40%) | [139] | ||
S. aureus (NCTC 1803) | 210.00 μg/mL | |||||
S. aureus (ATCC 25923) | n.m. | 0.40 mg/mL | NCR | [85] | ||
ADM | S. aureus (ATCC 433000) | Ethanol | 0.25 μL/mL | Thymol (38.1%), p-cymene (29.10%) | [182] | |
S. aureus (2 multidrug-resistant clinical strains from hands) | 0.50 μL/mL | Thymol (38.1%), p-cymene (29.10%) | [182] | |||
S. aureus (6 multidrug-resistant clinical strains from wounds) | 0.50–1.00 μL/mL | |||||
S. aureus (4 multidrug-resistant clinical strains from ulcers) | 0.50–0.75 μL/mL | |||||
S. aureus (multidrug-resistant clinical strain from abscesses) | 0.25 μL/mL | |||||
MIC | S. aureus (ATCC 12600) | Acetone | 1.30 mg/mL | Thymol (47.20%), p-cymene (22.10%) | [140] | |
MRSA (15 clinical isolates) | Ethanol | 0.50% v/v | NCR | [136] | ||
ADM | MRSA (ATCC 33592) | Tween 20 | 18.50 μg/mL | Thymol (48.1%), p-cymene (15.60%), γ-terpinene (15.40%) | [81] | |
S. aureus (ATCC 25922) | ||||||
MRSA (14 clinical isolates) | 18.50–37.00 μg/mL | |||||
MIC | S. aureus (ATCC 6538) | Acetone | 3.33 mg/mL | p-Cymene (39.90%), thymol (20.70%) | [99] | |
| ||||||
Thymus vulgaris (thyme) (thymol chemotype) | MAC | S.aureus (CECT 239) | 95% ethanol | <0.20 μL/mL | p-Cymene (18.70%), thymol (57.70%) | [61] |
Thymus zygis subsp. gracilis (thyme) (thymol and two linalool chemotypes) | <0.20–1.20 μL/mL | p-Cymene (0.50–11.20%), (E)-sabinene hydrate (0.20–18.20%), linalool (2.00–82.30%) | ||||
| ||||||
Vetiveria zizanioides/Andropogon muricatus (vetiver) | MIC | S. aureus (ATCC 6538) | Acetone | 0.75 mg/mL | Zizanol (13.6%), β-vetirenene (7.2%) | [99] |
aScientific name (common name), part of plant (if applicable).
bMIC: microdilution method; MAC: macrodilution method; ADM: agar dilution method; CTA: contact time assay.
cAmerican Type Culture Collection, Rockville, USA (ATCC); Colección Espanõla de Cultivos Tipo (CECT); collection of microorganisms of the Department of Microbiology (MFBF); culture collection of antibiotics resistant microbes (CCRM); Eskişehir Osmangazi University, Faculty of Medicine, clinical isolate (OGU); Laboratorio de Microbiología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina (LM); Microbial Type Culture Collection (MTCC); Mycology Laboratory (LM); National Center of Industrial Microorganisms (NCIM); National Collection of Type Cultures, London, Great Britain (NCTC); Spanish Collection of Type Cultures (STCC).
dDMSO concentration was not included; n.m.: not mentioned.
eNI: no inhibition.
fNCR: no composition results reported.